90 related articles for article (PubMed ID: 8896647)
1. Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria.
Yip JW; Jones C; Facchini F; Chen I; Reaven GM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):959-63. PubMed ID: 8896647
[TBL] [Abstract][Full Text] [Related]
2. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals.
Su HY; Sheu WH; Chin HM; Jeng CY; Chen YD; Reaven GM
Am J Hypertens; 1995 Nov; 8(11):1067-71. PubMed ID: 8554729
[TBL] [Abstract][Full Text] [Related]
3. Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study.
Sheu W; Jeng CY; Fuh M; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1996 Mar; 81(3):1156-9. PubMed ID: 8772592
[TBL] [Abstract][Full Text] [Related]
4. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
Hoffmann IS; Jimenez E; Cubeddu LX
J Hum Hypertens; 2001 Jun; 15(6):407-12. PubMed ID: 11439316
[TBL] [Abstract][Full Text] [Related]
5. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
7. Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension.
Bianchi S; Bigazzi R; Nenci R; Campese VM
J Nephrol; 1997; 10(6):325-33. PubMed ID: 9442446
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension.
Zavaroni I; Ardigo D; Rossi PC; Zuccarelli A; Pacetti E; Monti L; Piatti PM; Reaven GM
Am J Hypertens; 2004 Jul; 17(7):549-52. PubMed ID: 15233972
[TBL] [Abstract][Full Text] [Related]
11. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai].
Li Q; Jia WP; Lu JQ; Chen L; Wu YM; Jiang SY; Xiang KS
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jan; 25(1):65-8. PubMed ID: 15061951
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
[TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria in essential hypertension.
Bianchi S; Bigazzi R; Campese VM
J Nephrol; 1997; 10(4):216-9. PubMed ID: 9377730
[TBL] [Abstract][Full Text] [Related]
15. Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjects.
Zavaroni I; Platti PM; Monti LD; Gasparini P; Barilli LA; Massironi P; Ardigo D; Valsecchi G; Delsignore R; Reaven GM
Metabolism; 2000 Aug; 49(8):959-61. PubMed ID: 10954010
[TBL] [Abstract][Full Text] [Related]
16. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.
Facchini FS; Stoohs RA; Reaven GM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):1013-7. PubMed ID: 8896654
[TBL] [Abstract][Full Text] [Related]
18. Essential hypertension: an insulin-resistant state.
Ferrannini E; Haffner SM; Stern MP
J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S18-25. PubMed ID: 1694927
[TBL] [Abstract][Full Text] [Related]
19. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Ariza CR; Frati AC; Gómez G; Almazán A
Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
